Literature DB >> 2400640

Metabolic chiral inversion of ibuprofen in isolated rat hepatocytes.

S Müller1, J M Mayer, J C Etter, B Testa.   

Abstract

Ibuprofen was used to demonstrate that isolated rat hepatocytes offer a suitable in vitro model to investigate the metabolic chiral inversion of anti-inflammatory 2-arylpropionic acids (profens). The inversion of the pharmacologically inactive (-)-(R)-ibuprofen to the active (+)-(S)-ibuprofen was shown to obey apparent first-order kinetics during 5 h and to increase linearly with increasing hepatocyte concentration up to 4 x 10(5) cells/ml. No elimination of (R)-ibuprofen by routes other than inversion was seen, whereas the elimination of (S)-ibuprofen appeared to be saturable.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2400640     DOI: 10.1002/chir.530020203

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  5 in total

Review 1.  Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs.

Authors:  A M Evans
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Interpretation of in Vitro Metabolic Stability Studies for Racemic Mixtures.

Authors:  James A Baker; Michael D Altman; Iain J Martin
Journal:  ACS Med Chem Lett       Date:  2018-07-19       Impact factor: 4.345

3.  The effects of liver and renal disease on stereoselective serum binding of flurbiprofen.

Authors:  R Blouin; I Chaudhary; K Nishihara; S Cox
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335

4.  Pharmacokinetics of the enantiomers of ibuprofen in the rabbit.

Authors:  K M Williams; R D Knihinicki; R O Day
Journal:  Agents Actions       Date:  1991-11

5.  The stereospecificity of flobufen metabolism in isolated guinea pig hepatocytes.

Authors:  Radim Kral; Lenka Skalova; Barbora Szotakova; Jakub Velik; Ladislava Schroterova; Yogeeta N Babu; Vladimir Wsol
Journal:  BMC Pharmacol       Date:  2003-06-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.